Furthermore, certain molecular metabolites of the AEG-1 knockout cell lines were measured using 1H MRS, the relationship between metabolite changes and AEG-1 expression was explored, and certain metabolite ratios were determined as a noninvasive imaging biomarker for preoperative evaluation and an indicator of targeted therapy for glioma. This evidence concerns the gene MTDH and central nervous system cancer.